These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 907897)

  • 41. Studies on the dual action of guanethidine in sympathetic nerves.
    Lundborg P; Stitzel RE
    Acta Physiol Scand; 1968; 72(1):100-7. PubMed ID: 5655744
    [No Abstract]   [Full Text] [Related]  

  • 42. Persistent neuronal blockade with guanethidine in dog mesenteric arteries.
    Clarke DE; Buckley JP
    J Pharm Pharmacol; 1978 Apr; 30(4):266-8. PubMed ID: 24725
    [No Abstract]   [Full Text] [Related]  

  • 43. Guanethidine.
    Woosley RL; Nies AS
    N Engl J Med; 1976 Nov; 295(19):1053-7. PubMed ID: 972658
    [No Abstract]   [Full Text] [Related]  

  • 44. Modification of sympathetic nerve stimulation frequency-response relationship in rabbit ileum by guanethidine, bretylium and tetracaine.
    Kihara M; Kubo T; Misu Y
    Arch Int Pharmacodyn Ther; 1983 Dec; 266(2):180-5. PubMed ID: 6667066
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The importance of catecholamine uptake inhibition in the reversal of guanethidine blockade of adrenergic neurons.
    Lee CH; Strosberg AM; Warren LA
    Res Commun Chem Pathol Pharmacol; 1980 Oct; 30(1):3-14. PubMed ID: 7433767
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Time-course effects of oral guanethidine administration on cardiovascular and autonomic effects on dogs.
    Jandhyala BS; Cavero I; Buckley JP
    Eur J Pharmacol; 1976 Mar; 36(1):21-32. PubMed ID: 1261592
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bretylium and guanethidine: two new drugs producing specific blockade of the sympathetic nervous system.
    FREIS ED
    Heart Bull; 1960; 9():88-9. PubMed ID: 13824829
    [No Abstract]   [Full Text] [Related]  

  • 48. [Treatment of algodystrophy with regional intravenous block using guanethidine].
    Kipper R; Helmer J; Vivin P; Fossard JP; Thome M; Delagoutte JP
    Cah Anesthesiol; 1988 May; 36(3):183-90. PubMed ID: 3395905
    [No Abstract]   [Full Text] [Related]  

  • 49. [Intravenous block with guanethidine in the treatment of of hyperpathic painful conditions of the extremities].
    Nørregaard TV; Schurizek BA; Husegaard HC
    Ugeskr Laeger; 1982 Oct; 144(43):3162-4. PubMed ID: 7157533
    [No Abstract]   [Full Text] [Related]  

  • 50. Evaluation of the central and peripheral components for induction of postural hypotension by guanethidine, clonidine, dopamine2 receptor agonists and 5-hydroxytryptamine1A receptor agonists.
    Park KH; Long JP; Cannon JG
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1221-30. PubMed ID: 1762069
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of neuronal activity levels on the cytotoxic effects of guanethidine.
    Evans BK
    J Pharmacol Exp Ther; 1979 May; 209(2):205-14. PubMed ID: 438995
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pain relief following post-ganglionic sympathetic blockade with I.V. guanethidine.
    Glynn CJ; Basedow RW; Walsh JA
    Br J Anaesth; 1981 Dec; 53(12):1297-302. PubMed ID: 7317248
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Guanethidine blockade for palliative treatment in reflex dystrophy].
    Nielsen FB; Olesen AS
    Ugeskr Laeger; 1992 May; 154(21):1500-2. PubMed ID: 1376006
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Local chemical sympathectomy of rat bone marrow and its effect on marrow cell composition.
    Dubový P; Klusáková I; Kučera L; Osičková J; Chovancová J; Loja T; Mayer J; Doubek M; Joukal M
    Auton Neurosci; 2017 Sep; 206():19-27. PubMed ID: 28688831
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Partial reversal of guanethidine-induced adrenergic neuron blockade by acetaldehyde.
    Lai FM; Hudgins PM
    Toxicol Appl Pharmacol; 1975 May; 32(2):377-84. PubMed ID: 1154401
    [No Abstract]   [Full Text] [Related]  

  • 56. [Controlled circulatory blockade. Historical principles and future perspectives].
    Acevedo A
    Wien Med Wochenschr; 1993; 143(7-8):144-6; discussion 147. PubMed ID: 8379163
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Thrombosis of the atrial cavity caused by sound stimulus in rats after the exposure of the sympathetic nervous system to the action of guanethidine].
    Rodionov IM; Mukhsmedov A; Poletaeva II; Iarygin VN
    Kardiologiia; 1975 Mar; 15(3):138-9. PubMed ID: 1170460
    [No Abstract]   [Full Text] [Related]  

  • 58. Intravenous regional guanethidine treatment in peripheral vascular disease.
    Olshwang D; Beer G; Magora F
    Angiology; 1980 Sep; 31(9):639-45. PubMed ID: 7212382
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical response to regional intravenous guanethidine in patients with rheumatoid arthritis.
    Levine JD; Fye K; Heller P; Basbaum AI; Whiting-O'Keefe Q
    J Rheumatol; 1986 Dec; 13(6):1040-3. PubMed ID: 3550071
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vascular and nociceptive effects of localized prolonged sympathetic blockade in human skin.
    Lipnicki DM; Drummond PD
    Auton Neurosci; 2001 Apr; 88(1-2):86-93. PubMed ID: 11474550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.